Correlation Between Kilitch Drugs and UCO Bank

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kilitch Drugs and UCO Bank at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kilitch Drugs and UCO Bank into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kilitch Drugs Limited and UCO Bank, you can compare the effects of market volatilities on Kilitch Drugs and UCO Bank and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kilitch Drugs with a short position of UCO Bank. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kilitch Drugs and UCO Bank.

Diversification Opportunities for Kilitch Drugs and UCO Bank

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between Kilitch and UCO is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Kilitch Drugs Limited and UCO Bank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UCO Bank and Kilitch Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kilitch Drugs Limited are associated (or correlated) with UCO Bank. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UCO Bank has no effect on the direction of Kilitch Drugs i.e., Kilitch Drugs and UCO Bank go up and down completely randomly.

Pair Corralation between Kilitch Drugs and UCO Bank

Assuming the 90 days trading horizon Kilitch Drugs Limited is expected to generate 0.96 times more return on investment than UCO Bank. However, Kilitch Drugs Limited is 1.04 times less risky than UCO Bank. It trades about 0.16 of its potential returns per unit of risk. UCO Bank is currently generating about -0.34 per unit of risk. If you would invest  33,360  in Kilitch Drugs Limited on October 10, 2024 and sell it today you would earn a total of  1,725  from holding Kilitch Drugs Limited or generate 5.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

Kilitch Drugs Limited  vs.  UCO Bank

 Performance 
       Timeline  
Kilitch Drugs Limited 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Kilitch Drugs Limited are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Kilitch Drugs may actually be approaching a critical reversion point that can send shares even higher in February 2025.
UCO Bank 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UCO Bank has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, UCO Bank is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Kilitch Drugs and UCO Bank Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kilitch Drugs and UCO Bank

The main advantage of trading using opposite Kilitch Drugs and UCO Bank positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kilitch Drugs position performs unexpectedly, UCO Bank can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UCO Bank will offset losses from the drop in UCO Bank's long position.
The idea behind Kilitch Drugs Limited and UCO Bank pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stocks Directory
Find actively traded stocks across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges